ArticlePathology oncology research : POR2020

Increased Expression of Gankyrin and Stemness Factor Oct-4 are Associated with Unfavorable Clinical Outcomes and Poor Benefit of Tamoxifen in Breast Carcinoma Patients.

Rosa Jahangiri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.